Categories
Disease Modifying Anti-rheumatic Drugs,DMARDs Golimumab Pharmacology Physiotherapy

Golimumab and Pharmacodynamics

In this article we will discuss Golimumab and Pharmacodynamics

In this article, we will discuss Golimumab and Pharmacodynamics. So, let’s get started.

Golimumab and Pharmacodynamics

In clinical studies, decreases in C-reactive protein (CRP), interleukin (IL)-6, matrix metalloproteinase 3 (MMP-3), intercellular adhesion molecule (ICAM)-l and vascular endothelial growth factor (VEOF) were observed following Golimumab administration in patients with RA, PsA, and AS.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.